Categories
News

Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs)

Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs)

Cancer is one of the leading causes of death, worldwide. In 2020 alone, over 19 million new cases of the disease (affecting different organs) and close 10 million associated fatalities, were reported worldwide. Over the next couple of decades, experts believe that the global cancer burden is likely to increase by almost 50%.

www.rootsanalysis.com/reports/immune-checkpoint-inhibitor…

Posted by RootsAnalysis on 2022-02-08 08:41:05

Tagged: , PD-1 , PD-L1 , immune checkpoint inhibitors , immune checkpoint inhibitors market , PD-1 inhibitors market , PD-L1 inhibitors market

Leave a Reply

Your email address will not be published. Required fields are marked *